Abstract
Although approximately 1% of the human population suffers from epilepsy, the cellular basis of this disease remains largely unresolved, and about 30% of all epilepsies are refractory to therapies using currently available drugs. Until recently, synchronous neuronal activity during seizures has been thought to be, entirely of neuronal origin, and the main stream of epilepsy research has focused on changes in membrane properties of neurons and on classical chemical neurotransmission between them. However, recent discoveries about neuron-astrocyte bidirectional communication strongly challenge this concept. These functions of astrocyte are proving significant in the understanding of epilepsy, stroke and many other neurological diseases. In addition, the most important function reported for gap junctional communication in the nervous system is the increased synchronous activity of the coupled cells. Based on the emergent evidence, it is likely that gap junctional communication plays a definite role in the associated neuronal/astrocytic networks being involved in the generation and propagation of seizure discharges in the epileptic brain. Therefore astrocytes and gap junctions as potentially new cellular targets may open new perspectives for targeted molecular therapeutic interventions and allow the development of new antiepileptic as well as anticonvulsant drugs.
Keywords: Astrocytes, anticonvulsant drugs, antiepileptic drugs, gap junctions, epilepsy
Current Signal Transduction Therapy
Title: Possible Exploitation of Non-Neuronal and Non-Chemical Synaptic Signalling Pathways in Epilepsy Therapy
Volume: 3 Issue: 3
Author(s): Magdolna Szente
Affiliation:
Keywords: Astrocytes, anticonvulsant drugs, antiepileptic drugs, gap junctions, epilepsy
Abstract: Although approximately 1% of the human population suffers from epilepsy, the cellular basis of this disease remains largely unresolved, and about 30% of all epilepsies are refractory to therapies using currently available drugs. Until recently, synchronous neuronal activity during seizures has been thought to be, entirely of neuronal origin, and the main stream of epilepsy research has focused on changes in membrane properties of neurons and on classical chemical neurotransmission between them. However, recent discoveries about neuron-astrocyte bidirectional communication strongly challenge this concept. These functions of astrocyte are proving significant in the understanding of epilepsy, stroke and many other neurological diseases. In addition, the most important function reported for gap junctional communication in the nervous system is the increased synchronous activity of the coupled cells. Based on the emergent evidence, it is likely that gap junctional communication plays a definite role in the associated neuronal/astrocytic networks being involved in the generation and propagation of seizure discharges in the epileptic brain. Therefore astrocytes and gap junctions as potentially new cellular targets may open new perspectives for targeted molecular therapeutic interventions and allow the development of new antiepileptic as well as anticonvulsant drugs.
Export Options
About this article
Cite this article as:
Szente Magdolna, Possible Exploitation of Non-Neuronal and Non-Chemical Synaptic Signalling Pathways in Epilepsy Therapy, Current Signal Transduction Therapy 2008; 3 (3) . https://dx.doi.org/10.2174/157436208785699677
DOI https://dx.doi.org/10.2174/157436208785699677 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Emerging Role of Coenzyme Q-10 in Aging, Neurodegeneration, Cardiovascular Disease, Cancer and Diabetes Mellitus
Current Neurovascular Research Anesthetics as Chemical Tools to Study the Structure and Function of Nicotinic Acetylcholine Receptors
Current Protein & Peptide Science The Therapeutic Role of Electroencephalography in Deep Brain Stimulation in Intractable Epilepsy: A Recent Perspective
Recent Patents and Topics on Imaging (Discontinued) Synthesis of 3,4–Dihydropyrimidin–2-ones (DHPMs) Using Highly Efficient Recyclable Silica Supported Rhodium Chloride as Heterogeneous Catalyst and their Anti-Neuroinflammatory Activity
Letters in Drug Design & Discovery Propofol: Therapeutic Indications and Side-Effects
Current Pharmaceutical Design Herbal and Holistic Solutions for Neurodegenerative and Depressive Disorders: Leads from Ayurveda
Current Pharmaceutical Design Nicotinic Receptors in Neurodegeneration
Current Neuropharmacology Statins, Mevalonate Pathway and its Intermediate Products in Placental Development and Preeclampsia
Current Molecular Pharmacology Calixarene: A Versatile Material for Drug Design and Applications
Current Pharmaceutical Design Lower Frequency of co-Morbid Medical Disorders Related to Poor Impulse Control in Parkinson’s than Alzheimer’s Disease
Current Aging Science Developing Pharmacotherapies for Cannabis and Cocaine Use Disorders
Current Neuropharmacology The Quantitative Structure-Activity Relationships between GABAA Receptor and Ligands based on Binding Interface Characteristic
Current Computer-Aided Drug Design New Highlights in the Regulation of Cells Proliferation
Neuroscience and Biomedical Engineering (Discontinued) Cognitive Dysfunction in Major Depressive Disorder: A State-of-the-Art Clinical Review
CNS & Neurological Disorders - Drug Targets Amyloid β Oligomers Decrease Hippocampal Spontaneous Network Activity in an Age-Dependent Manner
Current Alzheimer Research Editorial (Thematic Issue: Current Research on Cannabis Use Disorder)
Current Pharmaceutical Design Application of Contemporary Neuroproteomic Techniques in Unravelling Neurological Disorders
Current Protein & Peptide Science Pregabalin in Neuropathic Pain: Evidences and Possible Mechanisms
Current Neuropharmacology In Silico Approaches Towards the Understanding of the Structure- Function Relationships in Metabotropic Glutamate Receptors (mGluRs) and other Family C GPRCs
Current Pharmaceutical Design Histone Variants and Composition in the Developing Brain: Should MeCP2 Care?
Current Topics in Medicinal Chemistry